| | | | | | | | | | |
|
| |
|
| Dockets Entered
On October 25, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2003H-0432
|
| Civil Money Penalty, Korangy Radiology Associates, PA
|
|
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| 2004P-0074
|
| oxandrolone and widely used anti-coagulant durgs containing the active drug warfarin
|
|
|
|
|
| 2004P-0326
|
| ANDA for Adenosine Injection, USP 3 mg/mL with 6 mL and 10 mL fill volumes
|
|
|
|
|
| 2004S-0233
|
| Stimulating Innovation in Medical Technologies
|
|
| |
|
| 2003H-0432
|
| Civil Money Penalty, Korangy Radiology Associates, PA
|
|
|
| LET
9
|
| GCF-1
|
| Vol #:
|
| 4
|
|
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
|
|
| EXT
3
|
| Air Liquide America
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| APE 7
|
| Accium BioSciences
|
| Vol #:
|
| 1
|
|
|
|
|
| APE 8
|
| Harbor UCLA Medical Ctr; USCL School of Med., AMI/PET Radiopharmaceutical Committee
|
| Vol #:
|
| 1
|
|
|
|
|
| APE 9
|
| Society of Nuclear Medicine
|
| Vol #:
|
| 1
|
|
|
|
|
| APE 10
|
| Emory University School of Medicine
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0074
|
| oxandrolone and widely used anti-coagulant durgs containing the active drug warfarin
|
|
|
|
|
| C
3
|
| Heller Ehrman
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0326
|
| ANDA for Adenosine Injection, USP 3 mg/mL with 6 mL and 10 mL fill volumes
|
|
|
| SUP
2
|
| Fujisawa Healthcare, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004S-0233
|
| Stimulating Innovation in Medical Technologies
|
|
|
|
|
| APE 1
|
| AdvaMed Advanced Medical Technology Association
|
| Vol #:
|
| 2
|
|
